Categoria
Nasacort Hfa
Nombres de marca,
Nasacort Hfa
Analogos
Nasacort Hfa
Marca los nombres de mezcla
Aristoform R Crm 0.1% (Clioquinol + Triamcinolone Acetonide) Derma-4 Ont (Neomycin Sulfate + Nystatin + Thiostrepton (Antibiotic of a Streptomyces Species) + Triamcinolone Acetonide) Kenacomb Cream (Gramicidin + Neomycin Sulfate + Nystatin + Triamcinolone Acetonide) Kenacomb Mild Cream (Gramicidin + Neomycin Sulfate + Nystatin + Triamcinolone Acetonide) Kenacomb Mild Ointment (Gramicidin + Neomycin Sulfate + Nystatin + Triamcinolone Acetonide) Kenacomb Ointment (Gramicidin + Neomycin Sulfate + Nystatin + Triamcinolone Acetonide) Kenacomb Ont (Gramicidin + Neomycin (Neomycin Sulfate) + Nystatin + Triamcinolone Acetonide) Mecomb Crm 0.1% (Gramicidin + Neomycin (Neomycin Sulfate) + Nystatin + Triamcinolone Acetonide) Oribiotic Ointment (Bacitracin + Lidocaine + Neomycin (Neomycin Sulfate) + Nystatin + Triamcinolone Acetonide) Panolog Cream (Neomycin (Neomycin Sulfate) + Nystatin + Thiostrepton (Antibiotic of a Streptomyces Species) + Triamcinolone Acetonide) Panolog Ointment (Neomycin (Neomycin Sulfate) + Nystatin + Thiostrepton (Antibiotic of a Streptomyces Species) + Triamcinolone Acetonide) Ratio-Triacomb Regular Cream (Gramicidin + Neomycin (Neomycin Sulfate) + Nystatin + Triamcinolone Acetonide) Solvaderm Ointment (Neomycin (Neomycin Sulfate) + Nystatin + Thiostrepton (Antibiotic of a Streptomyces Species) + Triamcinolone Acetonide) Theraderm Cream (Gramicidin + Neomycin (Neomycin Sulfate) + Nystatin + Triamcinolone Acetonide) Viaderm Kc Crm (Gramicidin + Neomycin (Neomycin Sulfate) + Nystatin + Triamcinolone Acetonide) Viaderm Kc Ont (Gramicidin + Neomycin (Neomycin Sulfate) + Nystatin + Triamcinolone Acetonide)
Nasacort Hfa
Formula quimica
C21H27FO6
Nasacort Hfa
RX enlace
http://www.rxlist.com/cgi/generic/triamaer.htm
Nasacort Hfa
FDA hoja
Nasacort Hfa
MSDS (hoja de seguridad de materiales)
Nasacort Hfa
Sintesis de referencia
Fried et al., J. Am. Chem. .. Soc. 80, 2338 (1958)
Nasacort Hfa
Peso molecular
394.434 g/mol
Nasacort Hfa
Punto de fusion
274 - 278 (dec) oC
Nasacort Hfa
H2O Solubilidad
80 mg / L
Nasacort Hfa
Estado
Solid
Nasacort Hfa
LogP
0.329
Nasacort Hfa
Formas de dosificacion
Crema, líquido, los inhaladores de dosis (aerosol), ungüento, pasta, suspensión, jarabe, Tablet
Nasacort Hfa
Indicacion
Para el tratamiento de la rinitis alérgica perenne y estacional.
Nasacort Hfa
Farmacologia
Triamcinolona y sus derivados son glucocorticoides sintéticos que se utilizan por sus propiedades antiinflamatorias o inmunosupresoras.
Nasacort Hfa
Absorcion
Rápida absorción tras la administración oral
Nasacort Hfa
Toxicidad
LD50 => 500mg/kg (en ratas)
Nasacort Hfa
Informacion de Pacientes
Patients being treated with Azmacort Inhalation Aerosol should receive the following information and instructions.
This information is intended to aid them in the safe and effective use of this medication. It is not a complete
disclosure of all possible adverse or intended effects.
Patients should use Azmacort Inhalation Aerosol at regular intervals as directed. Results of clinical trials
indicate that significant improvement in asthma may occur by 1 week, but maximum benefit may not be achieved for 2
weeks or more. The patient should not increase the prescribed dosage but should contact the physician if symptoms do
not improve or if the condition worsens.
In clinical studies and post-marketing experience with Azmacort Inhalation Aerosol, local infections of the
oropharynx with Candida albicans have occurred. When such an infection develops, it should be treated with
appropriate local or systemic (i.e., oral antifungal) therapy while remaining on treatment with Azmacort
Inhalation Aerosol. However, at times therapy with Azmacort Inhalation Aerosol may need to be interrupted.
Patients should be instructed to track their use of Azmacort Inhalation Aerosol and to dispose of the canister
after 240 actuations since reliable dose delivery cannot be assured after 240 doses.
Patients who are on immunosuppressant doses of corticosteroids should be warned to avoid exposure to chickenpox or
measles and if exposed, to obtain medical advice.
Nasacort Hfa
Organismos afectados
Humanos y otros mamíferos